Turnstone Biologics Corp. Proceeds from Stock Options Exercised
Turnstone Biologics Corp. reported Proceeds from Stock Options Exercised of $44.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2025-08-08
- Turnstone Biologics Corp. proceeds from stock options exercised for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Turnstone Biologics Corp. proceeds from stock options exercised for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Turnstone Biologics Corp. proceeds from stock options exercised for the quarter ending 2023-12-31 was $10.00K, a 100.00% increase year-over-year.
- Turnstone Biologics Corp. proceeds from stock options exercised for the quarter ending 2023-09-30 was $9.00K, a 350.00% increase year-over-year.
- Turnstone Biologics Corp. proceeds from stock options exercised for fiscal 2024 was $44.00K, a 58.10% decline from fiscal 2023.
- Turnstone Biologics Corp. proceeds from stock options exercised for fiscal 2023 was $105.00K, a 33.12% decline from fiscal 2022.
- Turnstone Biologics Corp. proceeds from stock options exercised for fiscal 2022 was $157.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $44.00K 10-K · filed 2025-03-31 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $44.00K 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | $44.00K 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $19.00K derived: sum of 2 quarters · filed 2025-03-31 | $22.00K derived: sum of 3 quarters · filed 2025-03-31 | $105.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $12.00K derived: sum of 2 quarters · filed 2024-11-12 | $95.00K 10-Q · filed 2024-11-12 | $100.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $86.00K 10-Q · filed 2024-08-14 | $91.00K derived: sum of 3 quarters · filed 2024-08-14 | $93.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $83.00K 10-Q · filed 2024-05-13 | $88.00K derived: sum of 2 quarters · filed 2024-05-13 | $90.00K derived: sum of 3 quarters · filed 2024-05-13 | |
| 2022-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $7.00K derived: sum of 2 quarters · filed 2024-03-22 | $157.00K 10-K · filed 2024-03-22 | |
| 2022-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $152.00K 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $150.00K 10-Q · filed 2023-09-01 |